ArticleJournal of medicinal chemistry2023

Discovery of KB-0742, a Potent, Selective, Orally Bioavailable Small Molecule Inhibitor of CDK9 for MYC-Dependent Cancers.

David B Freeman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.